Anaplastic thyroid cancer: Rare, fatal, and neglected

被引：25
作者：
Kebebew, Electron [1 ]
机构：
[1] NCI, Endocrine Oncol Branch, Bethesda, MD 20892 USA
来源：
SURGERY | 2012年 / 152卷 / 06期
关键词：
VEMURAFENIB; CARCINOMA; SURVIVAL; MELANOMA;
D O I：
10.1016/j.surg.2012.08.059
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1088 / 1089
页数：2
相关论文
共 9 条
  • [1] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2507 - 2516
  • [2] ClinicalTrials.gov, OP STUD THYR CANC
  • [3] Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
    Harris, Pamela Jo
    Bible, Keith C.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1357 - 1375
  • [4] Anaplastic thyroid carcinoma - Treatment outcome and prognostic factors
    Kebebew, E
    Greenspan, FS
    Clark, OH
    Woeber, KA
    McMillan, A
    [J]. CANCER, 2005, 103 (07) : 1330 - 1335
  • [5] Anaplastic thyroid carcinoma: A 50-year experience at a single institution
    McIver, B
    Hay, ID
    Giuffrida, DF
    Dvorak, CE
    Grant, CS
    Thompson, GB
    van Heerden, JA
    Goellner, JR
    [J]. SURGERY, 2001, 130 (06) : 1028 - 1034
  • [6] Late Intervention with anti-BRAFV600E Therapy Induces Tumor Regression in an Orthotopic Mouse Model of Human Anaplastic Thyroid Cancer
    Nehs, Matthew A.
    Nucera, Carmelo
    Nagarkatti, Sushruta S.
    Sadow, Peter M.
    Morales-Garcia, Dieter
    Hodin, Richard A.
    Parangi, Sareh
    [J]. ENDOCRINOLOGY, 2012, 153 (02) : 985 - 994
  • [7] Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
    Smallridge, Robert C.
    Marlow, Laura A.
    Copland, John A.
    [J]. ENDOCRINE-RELATED CANCER, 2009, 16 (01) : 17 - 44
  • [8] Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer
    Sosa, Julie A.
    Balkissoon, Jai
    Lu, Shiao-ping
    Langecker, Peter
    Elisei, Rossella
    Jarzab, Barbara
    Bal, C. S.
    Marur, Shanthi
    Gramza, Ann
    Ondrey, Frank
    [J]. SURGERY, 2012, 152 (06) : 1078 - 1086
  • [9] Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
    Sosman, Jeffrey A.
    Kim, Kevin B.
    Schuchter, Lynn
    Gonzalez, Rene
    Pavlick, Anna C.
    Weber, Jeffrey S.
    McArthur, Grant A.
    Hutson, Thomas E.
    Moschos, Stergios J.
    Flaherty, Keith T.
    Hersey, Peter
    Kefford, Richard
    Lawrence, Donald
    Puzanov, Igor
    Lewis, Karl D.
    Amaravadi, Ravi K.
    Chmielowski, Bartosz
    Lawrence, H. Jeffrey
    Shyr, Yu
    Ye, Fei
    Li, Jiang
    Nolop, Keith B.
    Lee, Richard J.
    Joe, Andrew K.
    Ribas, Antoni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (08) : 707 - 714
1